Hemic and Lymphatic Diseases: News and Research on Blood Coagulation Disorders

MeSH tree: C15.378.100

FDA approves Hympavzi for hemophilia

The U.S. Food and Drug Administration (FDA) approved Hympavzi (marstacimab-hncq) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients aged 12 years and older with ...

Points to consider in hyperinflammation

Hemophagocytic lymphohistiocytosis (HLH) and macrophage activation syndrome (MAS) are life-threatening systemic hyperinflammatory syndromes. Systemic hyperinflammation and HLH/MAS can occur in nearly any inflammatory state, ...

page 3 from 6